Dive into this Researcher Update to learn about new funding and research opportunities and interesting survey results.
The aim of this study is to investigate seizure improvement after switching AEDs to once-daily dosing regimens in patients with drug-resistant epilepsy related to AED non-adherence. Successful switching was defined by at least 70% reduction in seizure frequency without troublesome adverse events.
The compound developed by Chang and Chou, a modified form of naturally occurring vitamin K, completely eliminated seizure activity in the mouse models.
In this update, learn how we're supporting critical research projects and you – our community.
SUDEP
With better mechanistic understanding of SUDEP, this team suggests changes for detection and classification to increase survival rates and improve risk stratification.
Children, teens, and young adults with a history of childhood epilepsy are at greater risk of self-injurious behavior, highlighting the need for careful screening of mental health concerns as part of routine epilepsy care.
More than 90% of patients gave the visit and provider experience the maximum rating, with a nearly 60% response rate on the post?visit survey.
To assist healthcare professionals, this team developed a pragmatic algorithm aimed at facilitating medication selection for individuals whose epilepsy begins at age 10 years and older.
Pediatric Epilepsy
The FDA approved Epidiolex oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.
